Vhi webinar sets out framework for healthcare professionals to support patients in making healthcare decisions ...
Introduction: Survivors of severe COVID-19 (Coronavirus Disease 2019) frequently experience long-term functional impairment, a condition known as post-COVID syndrome. As these patients may eventually ...
The Gujarat High Court has held that not all injuries result in loss of earning capacity and thus it is necessary to assess the functional disability while considering grant of compensation to a ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten), 5 ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company’s First ...
Objective This study aimed to determine the proportion of capacity challenges for refusal of care, the risk factors that may trigger challenges to capacity and to consider the implications of ...
Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical ...
Background: The patient’s somatic health status plays an important role in the factors predisposing to the development of depression. Any disease, especially a chronic one, often associated with pain, ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Semaglutide, a GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback